Eye drop gel shows promise for faster skin graft healing
NCT ID NCT03579160
First seen Jun 13, 2026 · Last updated Jun 13, 2026
Summary
This study tested whether a gel containing timolol, a drug usually used for glaucoma, can improve healing and appearance of full-thickness skin grafts after skin cancer removal. The trial planned to enroll 82 adults but was terminated early with only 10 participants. The goal was to see if the gel speeds up wound closure and improves scar quality compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL WOUND are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital
Boston, Massachusetts, 02130, United States
Conditions
Explore the condition pages connected to this study.